Gossamer Bio, Inc. (GOSS) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	-0.1
Selling, general and administrative [+]	47.6	45.8	49.7	39.1	44.1	0.3	-0.1
General and administrative	47.6	45.8	49.7	39.1	44.1	0.3
Research and development	170.9	170.3	160.9	143.4	55.3	0.9
Other operating expenses							0.1
EBITDA [+]	-216.7	-214.3	-209.2	-181.6	-99.0
EBITDA growth	1.1%	2.5%	15.2%	83.4%	8489.5%	1289.2%
Depreciation and amortization	1.8	1.7	1.4	0.9	0.3
EBIT [+]	-218.5	-216.0	-210.6	-182.5	-99.3	-1.2	-0.1
EBIT growth	1.1%	2.6%	15.4%	83.8%	8515.3%	1289.2%
Non-recurring items [+]	0.1	0.1	23.4	3.6	49.7	5.5
In-process research & development	0.1	0.1	23.4	3.6	49.7	5.5
Interest expense	13.9	19.4	12.7	1.9	0.0
Interest expense	13.9	19.4	12.7	1.9	0.0
Other income (expense), net	3.1	1.6	3.3	7.8	2.0	13.4
Pre-tax income	-229.4	-234.0	-243.4	-180.3	-147.0	6.8	-0.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate			0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-229.4	-234.0	-243.4	-180.3	-147.0	-6.8	-0.1

Basic EPS [+]	($2.71)	($3.13)	($3.55)	($3.29)	($22.59)	($0.74)	($0.01)
Growth	-13.3%	-12.0%	7.8%	-85.4%	2956.8%	8057.8%
Diluted EPS [+]	($2.71)	($3.13)	($3.55)	($3.29)	($22.59)	($0.74)	($0.01)
Growth	-13.3%	-12.0%	7.8%	-85.4%	2956.8%	8057.8%

Shares outstanding (basic) [+]	84.6	74.8	68.5	54.7	6.5	9.2	9.2
Growth	13.0%	9.2%	25.2%	741.5%	-29.0%	0.0%
Shares outstanding (diluted) [+]	84.6	74.8	68.5	54.7	6.5	9.2	9.2
Growth	13.0%	9.2%	25.2%	741.5%	-29.0%	0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.